Document ID: chunk:federal_register_of_legislation:F2025C00211:reg:5:p4
Version: federal_register_of_legislation:F2025C00211
Segment Type: reg
Provision Reference: reg 5 (pt 4/9)
Character Range: 99158–101767

shall, within 14 days after receiving a notice in writing from the Secretary or an authorised person, furnish to the Secretary such information as is requested in the notice, being information with respect to:
 (i) the orders for drugs placed with the holder of the licence within such period immediately preceding the date of the notice as is specified in the notice;
 (ii) the orders for drugs that the holder of the licence reasonably expects to be placed with the holder within such period immediately following the date of the notice as is specified in the notice; or
 (iii) any proposal of the holder of the licence to manufacture or sell by wholesale, within such period immediately following the date of the notice as is specified in the notice, a drug that the holder has not previously manufactured or sold by wholesale;
 (j) the holder of the licence shall in respect of each permission to import a drug that is granted to the holder during the currency of the licence, being a permission that specifies a condition or requirement to be complied with by the holder, comply with that condition or requirement.
 (10) The Secretary or an authorised person shall not grant to an applicant a permission to import a drug unless:
 (a) the applicant has furnished all the information requested by the Secretary or authorised person under subregulation (6);
 (b) in the case of a drug that is included in Schedule 1 or 2 to the Single Convention:
 (i) where the drug is required by the applicant for the manufacture of a drug at certain premises—if the Narcotic Drugs Act 1967 applies in relation to that manufacture, the applicant is, for the purposes of that Act, the holder of a manufacturer's licence in relation to the manufacture of the last‑mentioned drug at those premises and, if, under a law of the State or Territory in which those premises are situated, the manufacture of that drug is prohibited unless a licence to manufacture the drug has been granted under that law, the applicant is, for the purposes of that law, the holder of a licence authorising the applicant to manufacture the drug at those premises;
 (ii) where the drug is required by the applicant for the purposes of the applicant's business as a seller or supplier of drugs—the applicant is, under a law of the State or Territory in which the premises at or from which the applicant conducts that business are situated, the holder of a licence authorising the applicant to sell or supply the drug at or from those premises; or
 (iii) where subparagraphs (i) and (ii) do not apply—the drug is required by the applicant for medical